J 
Jiangsu Yuyue Medical Equipment & Supply Co 002223.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
28.30
-2.18%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥7.96bn
FY2016FY2025
Net income
CN¥1.48bn
FY2016FY2025
Free cash flow
CN¥1.37bn
FY2016FY2025
Shareholders' equity
CN¥13.24bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥7.96bn | CN¥7.57bn | CN¥7.97bn | CN¥7.10bn | CN¥6.89bn | CN¥6.73bn | CN¥4.64bn | CN¥4.18bn | CN¥3.54bn | CN¥2.64bn |
| Gross profit | CN¥4.02bn | CN¥3.77bn | CN¥4.06bn | CN¥3.39bn | CN¥3.31bn | CN¥3.54bn | CN¥1.95bn | CN¥1.67bn | CN¥1.40bn | CN¥1.02bn |
| Research and development | CN¥570.1m | CN¥546.7m | CN¥504.4m | CN¥496.4m | CN¥425.7m | CN¥401.5m | CN¥235.1m | CN¥152.1m | CN¥125.7m | CN¥120.2m |
| Operating income | CN¥1.50bn | CN¥1.93bn | CN¥2.89bn | CN¥1.39bn | CN¥1.69bn | CN¥2.01bn | CN¥849.9m | CN¥776.2m | CN¥683.0m | CN¥541.0m |
| Net income | CN¥1.48bn | CN¥1.81bn | CN¥2.40bn | CN¥1.60bn | CN¥1.48bn | CN¥1.76bn | CN¥752.6m | CN¥727.2m | CN¥592.0m | CN¥499.8m |
| Diluted earnings per share | 1.48 | 1.81 | 2.39 | 1.67 | 1.48 | 1.76 | 0.75 | 0.73 | 0.59 | 0.50 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥16.08bn | CN¥15.65bn | CN¥15.97bn | CN¥15.10bn | CN¥12.00bn | CN¥10.09bn | CN¥7.97bn | CN¥6.91bn | CN¥6.63bn | CN¥5.82bn |
| Cash and short-term investments | — | CN¥6.74bn | CN¥7.29bn | CN¥7.35bn | CN¥4.67bn | CN¥3.39bn | CN¥1.56bn | CN¥1.67bn | CN¥2.05bn | CN¥3.27bn |
| Total liabilities | CN¥2.73bn | CN¥2.99bn | CN¥4.05bn | CN¥5.03bn | CN¥3.57bn | CN¥2.60bn | CN¥1.81bn | CN¥1.37bn | CN¥1.06bn | CN¥880.0m |
| Debt | — | CN¥383.3m | CN¥1.54bn | CN¥2.30bn | CN¥1.52bn | CN¥659.0m | CN¥195.0m | CN¥178.0m | CN¥150.0m | CN¥103.0m |
| Shareholders' equity | CN¥13.24bn | CN¥12.54bn | CN¥11.76bn | CN¥9.86bn | CN¥8.27bn | CN¥7.44bn | CN¥6.07bn | CN¥5.47bn | CN¥5.24bn | CN¥4.91bn |
| Shares outstanding | 998m | 997m | 1,002m | 957m | 1,002m | 1,002m | 1,003m | 1,003m | 1,002m | 1,006m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥1.50bn | CN¥1.82bn | CN¥2.13bn | CN¥2.30bn | CN¥1.20bn | CN¥2.83bn | CN¥614.2m | CN¥798.1m | CN¥242.1m | CN¥677.0m |
| Capital spending | −CN¥129.0m | −CN¥128.4m | −CN¥132.6m | −CN¥379.4m | −CN¥284.3m | −CN¥678.9m | −CN¥440.4m | −CN¥389.5m | −CN¥490.0m | −CN¥76.2m |
| Free cash flow | CN¥1.37bn | CN¥1.69bn | CN¥1.99bn | CN¥1.93bn | CN¥916.9m | CN¥2.15bn | CN¥173.8m | CN¥408.6m | −CN¥247.9m | CN¥600.8m |
| Dividends paid | −CN¥799.0m | −CN¥1.22bn | −CN¥597.7m | −CN¥350.8m | −CN¥318.8m | −CN¥401.0m | −CN¥159.3m | −CN¥155.8m | −CN¥271.8m | −CN¥240.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥2.20bn | CN¥2.37bn | CN¥1.41bn | CN¥1.89bn | CN¥2.22bn | CN¥2.44bn | CN¥1.54bn | CN¥1.72bn |
| Gross profit | CN¥1.09bn | CN¥1.19bn | CN¥729.7m | CN¥958.3m | CN¥1.11bn | CN¥1.23bn | CN¥748.2m | CN¥870.9m |
| Operating income | CN¥411.4m | CN¥521.9m | −CN¥43.1m | CN¥298.2m | CN¥650.0m | CN¥736.9m | CN¥178.3m | CN¥1.75bn |
| Net income | CN¥414.5m | CN¥428.3m | CN¥15.8m | CN¥263.3m | CN¥577.9m | CN¥624.8m | CN¥274.1m | CN¥411.4m |
| Diluted earnings per share | 0.42 | 0.43 | 0.02 | 0.26 | 0.58 | 0.63 | 0.27 | 0.41 |
| Cash from operations | — | — | — | CN¥358.0m | CN¥509.0m | CN¥659.0m | CN¥433.0m | CN¥368.0m |
| Capital spending | −CN¥21.0m | −CN¥27.0m | −CN¥26.0m | −CN¥41.0m | −CN¥30.0m | −CN¥30.0m | −CN¥64.0m | −CN¥21.0m |
| Free cash flow | — | — | — | CN¥317.0m | CN¥479.0m | CN¥629.0m | CN¥369.0m | CN¥347.0m |
| Total assets | CN¥16.90bn | CN¥16.89bn | CN¥16.08bn | CN¥16.67bn | CN¥16.53bn | CN¥16.42bn | CN¥15.65bn | CN¥15.49bn |
| Cash and short-term investments | — | — | — | CN¥7.46bn | CN¥7.37bn | CN¥7.09bn | CN¥6.74bn | CN¥6.68bn |
| Debt | — | — | — | CN¥716.8m | — | — | — | — |
| Shareholders' equity | CN¥13.33bn | CN¥13.65bn | CN¥13.24bn | CN¥13.52bn | CN¥13.30bn | CN¥13.11bn | CN¥12.54bn | CN¥12.53bn |
Financial ratios
Data as of 20 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 50.6% | 49.8% | 50.9% | 47.8% | 48.0% | 52.6% | — | — |
| Operating margin | 18.8% | 25.5% | 36.3% | 19.5% | 24.5% | 29.9% | — | — |
| Net margin | 18.6% | 23.9% | 30.1% | 22.5% | 21.5% | 26.2% | — | — |
| Return on equity | 11.2% | 14.4% | 20.4% | 16.2% | 17.9% | 23.7% | — | — |
| Return on assets | 9.2% | 11.5% | 15.0% | 10.6% | 12.4% | 17.4% | — | — |
| Free cash flow yield | 6.2% | 7.4% | 8.6% | 10.7% | 5.7% | 13.4% | — | — |
| Revenue growth | 5.1% | -5.1% | 12.3% | 3.0% | 2.5% | 45.1% | — | — |
| Earnings growth | -17.9% | -24.6% | 50.2% | 7.6% | -15.7% | 133.7% | — | — |
| Current ratio | 1.54x | 3.44x | 3.27x | 3.10x | 3.75x | 2.28x | — | — |
| Debt to equity | — | — | 0.06x | 0.16x | 0.18x | 0.09x | 0.02x | 0.03x |
| Equity ratio | 82.3% | 80.1% | 73.7% | 65.3% | 68.9% | 73.7% | — | — |
| Interest coverage | 250.01x | 89.14x | 47.47x | 23.45x | 52.29x | 126.91x | — | — |
| R&D as a share of sales | 7.2% | 7.2% | 6.3% | 7.0% | 6.2% | 6.0% | — | — |
| Buybacks as a share of market value | -0.1% | 0.5% | -4.7% | 4.5% | 0.0% | 0.0% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 3.9% | 3.4% | 14.2% |
| Operating income | 2.6% | -5.7% | 14.9% |
| Net income | -2.4% | -3.4% | 15.1% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 50.2% | 49.8% | 50.0% | 47.2% |
| Operating margin | 22.1% | 25.2% | 25.8% | 23.9% |
| Net margin | 21.2% | 23.8% | 23.8% | 21.9% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 25.7 | 20.1 | 14.5 | 19.1 | 25.6 | 16.1 | 27.1 | 27.0 | 33.2 | 41.6 |
| Price to sales | 4.8 | 4.8 | 4.3 | 4.3 | 5.5 | 4.2 | 4.4 | 4.7 | 5.5 | 7.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 10 years. Last went ex-dividend on 26 May 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.60 | 0.80 | 1.20 | 0.60 | 0.30 | 0.30 | 0.40 | 0.15 |
- 3-for-2 split · 26 May 2017
- 11-for-10 split · 21 May 2015
- 13-for-10 split · 22 May 2012
- 8-for-5 split · 27 May 2011
- 8-for-5 split · 27 May 2010
- 7-for-5 split · 22 Apr 2009
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.